Camrelizumab plus famitinib as first-line treatment for locally advanced or metastatic pulmonary sarcomatoid carcinomas (CAPSTONE): a multi-center, single-arm, phase 2 trial

eClinicalMedicine · Elsevier

Аннотация

Publication date: November 2026 Source: eClinicalMedicine, Volume 101 Author(s): Jizong Jiang, Yuxuan Wei, Bin Yang, Xianling Liu, Shundong Cang, Qibin Song, Huijuan Wang, Zheng Jin, Jun Wang, Feng Ye, Fenglin She, Hongyi Kou, Bo Zhu, Qian Chu

Читать у издателя →

Похожие статьи